Update of Intravitreal Steroids for the Treatment of Diabetic Macular Edema

被引：24

作者：

Bandello, Francesco ^{[1
]}

Preziosa, Chiara ^{[1
]}

Querques, Giuseppe ^{[1
]}

Lattanzio, Rosangela ^{[1
]}

机构：

[1] Univ Vita Salute, San Raffaele Sci Inst, Dept Ophthalmol, IT-20132 Milan, Italy

来源：

OPHTHALMIC RESEARCH | 2014年 / 52卷 / 02期

关键词：

Diabetic macular edema; Intravitreal pharmacotherapies; Steroids; Triamcinolone acetonide; Fluocinolone acetonide; Dexamethasone implant; ENDOTHELIAL GROWTH-FACTOR; DRUG-DELIVERY SYSTEM; RANDOMIZED CONTROLLED-TRIAL; ACETONIDE VITREOUS INSERTS; FLUOCINOLONE ACETONIDE; TRIAMCINOLONE ACETONIDE; DEXAMETHASONE IMPLANT; LASER TREATMENT; CLINICAL-TRIAL; RANIBIZUMAB;

D O I：

10.1159/000362764

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Diabetic macular edema is considered the most important factor related to visual impairment in patients with diabetic retinopathy. Together with the use of grid and focal laser photocoagulation, today the intravitreal administration of pharmacotherapies represents the standard of care for the treatment of this complication: anti-vascular endothelium growth factor agents and steroids are the drugs currently used for this aim. Differently from laser therapy, which prevents visual deterioration, the intravitreal approach allows the promotion of visual recovery. However, the intravitreal injections require to be repeated with high frequency, and this carries the risk of drug- and procedure-related adverse effects. (C) 2014 S. Karger AG, Basel

引用

页码：89 / 96

页数：8

共 57 条

[1]

[Anonymous], 2010, AM AC OPHTH RET PAN

[2]

[Anonymous], 2011, SUMM PROD CHAR 2011

[3] Risk factors for diffuse and focal macular edema [J].

Aroca, PR ;

Salvat, M ;

Fernández, J ;

Méndez, I .

JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2004, 18 (04) :211-215

[4] Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial [J].

Audren, Francois ;

Erginay, Ali ;

Haouchine, Belkacem ;

Benosman, Rym ;

Conrath, John ;

Bergmann, Jean-Francois ;

Gaudric, Alain ;

Massin, Pascale .

ACTA OPHTHALMOLOGICA SCANDINAVICA, 2006, 84 (05) :624-630

[5] Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema [J].

Avitabile, T ;

Longo, A ;

Reibaldi, A .

AMERICAN JOURNAL OF OPHTHALMOLOGY, 2005, 140 (04) :695-702

[6] Steroids as Part of Combination Treatment: The Future for the Management of Macular Edema? [J].

Bandello, F. ;

Parodi, M. Battaglia ;

Tremolada, G. ;

Lattanzio, R. ;

De Benedetto, U. ;

Iacono, P. .

OPHTHALMOLOGICA, 2010, 224 :41-45

[7]

Bandello F, 2013, CLIN STRATEGIES MANA

[8]

Beck RW, 2009, ARCH OPHTHALMOL-CHIC, V127, P245, DOI 10.1001/archophthalmol.2008.610

[9] Diabetic Macular Edema: Pathogenesis and Treatment [J].

Bhagat, Neelakshi ;

Grigorian, Ruben A. ;

Tutela, Arthur ;

Zarbin, Marco A. .

SURVEY OF OPHTHALMOLOGY, 2009, 54 (01) :1-32

[10] DEXAMETHASONE INTRAVITREAL IMPLANT FOR TREATMENT OF DIABETIC MACULAR EDEMA IN VITRECTOMIZED PATIENTS [J].

Boyer, David S. ;

Faber, David ;

Gupta, Sunil ;

Patel, Sunil S. ;

Tabandeh, Homayoun ;

Li, Xiao-Yan ;

Liu, Charlie C. ;

Lou, Jean ;

Whitcup, Scott M. .

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2011, 31 (05) :915-923

← 1 2 3 4 5 6 →